Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Grace Callagy"'
Autor:
Timothy B. Fisher, Geetanjali Saini, T. S. Rekha, Jayashree Krishnamurthy, Shristi Bhattarai, Grace Callagy, Mark Webber, Emiel A. M. Janssen, Jun Kong, Ritu Aneja
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-13 (2024)
Abstract Background Pathological complete response (pCR) is associated with favorable prognosis in patients with triple-negative breast cancer (TNBC). However, only 30–40% of TNBC patients treated with neoadjuvant chemotherapy (NAC) show pCR, while
Externí odkaz:
https://doaj.org/article/9bc17a375e25468388fa164cf619ad20
Autor:
Mohamed Zaakouk, Cecily Quinn, Elena Provenzano, Clinton Boyd, Grace Callagy, Soha Elsheikh, Joe Flint, Rebecca Millican-Slater, Anu Gunavardhan, Yasmeen Mir, Purnima Makhija, Silvana Di Palma, Susan Pritchard, Bruce Tanchel, Emad Rakha, Nehal M. Atallah, Andrew H.S. Lee, Sarah Pinder, Abeer M. Shaaban
Publikováno v:
Breast, Vol 70, Iss , Pp 82-91 (2023)
Background: Recent clinical evidence showed that breast cancer with low HER2 expression levels responded to trastuzumab deruxtecan therapy. The HER2-low cancers comprise immunohistochemistry (IHC) score 1+ and 2+ ISH non-amplified tumours, currently
Externí odkaz:
https://doaj.org/article/464b369375de4cabbec57321f8b22a03
Autor:
Mohamed Zaakouk, Mieke Van Bockstal, Christine Galant, Grace Callagy, Elena Provenzano, Roger Hunt, Corrado D’Arrigo, Nahla M. Badr, Brendan O’Sullivan, Jane Starczynski, Bruce Tanchel, Yasmeen Mir, Paul Lewis, Abeer M. Shaaban
Publikováno v:
Cancers, Vol 15, Iss 5, p 1511 (2023)
The assessment of PD-L1 expression in TNBC is a prerequisite for selecting patients for immunotherapy. The accurate assessment of PD-L1 is pivotal, but the data suggest poor reproducibility. A total of 100 core biopsies were stained using the VENTANA
Externí odkaz:
https://doaj.org/article/27a17d2016884714bb625c2b02f31043
Autor:
Bálint Cserni, Darren Kilmartin, Mark O’Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth, Simonetta Bianchi, Ewa Chmielik, Paulo Figueiredo, Giuseppe Floris, Maria Pia Foschini, Anikó Kovács, Päivi Heikkilä, Janina Kulka, Anne-Vibeke Laenkholm, Inta Liepniece-Karele, Caterina Marchiò, Elena Provenzano, Peter Regitnig, Angelika Reiner, Aleš Ryška, Anna Sapino, Elisabeth Specht Stovgaard, Cecily Quinn, Vasiliki Zolota, Mark Webber, Sharon A. Glynn, Rita Bori, Erika Csörgő, Orsolya Oláh-Németh, Tamás Pancsa, Anita Sejben, István Sejben, András Vörös, Tamás Zombori, Tibor Nyári, Grace Callagy, Gábor Cserni
Publikováno v:
Cancers, Vol 15, Iss 4, p 1199 (2023)
Tumour-infiltrating lymphocytes (TILs) reflect antitumour immunity. Their evaluation of histopathology specimens is influenced by several factors and is subject to issues of reproducibility. ONEST (Observers Needed to Evaluate Subjective Tests) helps
Externí odkaz:
https://doaj.org/article/b5737028920b4e1fa44a2db009fed358
Autor:
Gábor Cserni, Cecily M. Quinn, Maria Pia Foschini, Simonetta Bianchi, Grace Callagy, Ewa Chmielik, Thomas Decker, Falko Fend, Anikó Kovács, Paul J. van Diest, Ian O. Ellis, Emad Rakha, Tibor Tot, European Working Group for Breast Screening Pathology
Publikováno v:
Cancers, Vol 13, Iss 22, p 5694 (2021)
Triple-negative breast cancers (TNBC), as a group of tumours, have a worse prognosis than stage-matched non-TNBC and lack the benefits of routinely available targeted therapy. However, TNBC is a heterogeneous group of neoplasms, which includes some s
Externí odkaz:
https://doaj.org/article/16138480a83a426f85f5aec622bb0733
Autor:
Darren Kilmartin, Mark O’Loughlin, Xavier Andreu, Zsuzsanna Bagó-Horváth, Simonetta Bianchi, Ewa Chmielik, Gábor Cserni, Paulo Figueiredo, Giuseppe Floris, Maria Pia Foschini, Anikó Kovács, Päivi Heikkilä, Janina Kulka, Anne-Vibeke Laenkholm, Inta Liepniece-Karele, Caterina Marchiò, Elena Provenzano, Peter Regitnig, Angelika Reiner, Aleš Ryška, Anna Sapino, Elisabeth Specht Stovgaard, Cecily Quinn, Vasiliki Zolota, Mark Webber, Davood Roshan, Sharon A. Glynn, Grace Callagy
Publikováno v:
Cancers, Vol 13, Iss 17, p 4410 (2021)
Stromal tumour infiltrating lymphocytes (sTILs) are a strong prognostic marker in triple negative breast cancer (TNBC). Consistency scoring sTILs is good and was excellent when an internet-based scoring aid developed by the TIL-WG was used to score c
Externí odkaz:
https://doaj.org/article/000cc0d867314f44ae8d89acc4df4feb
Autor:
Shristi Bhattarai, Sergey Klimov, Karuna Mittal, Uma Krishnamurti, Xiaoxian (Bill) Li, Gabriela Oprea-Ilies, Ceyda Sonmez Wetherilt, Ansa Riaz, Mohammed A. Aleskandarany, Andrew R. Green, Ian O. Ellis, Guilherme Cantuaria, Meenakshi Gupta, Upender Manne, Johnson Agboola, Brett Baskovich, Emiel A. M. Janssen, Grace Callagy, Elaine M. Walsh, Anurag Mehta, Atika Dogra, Tanuja Shet, Pooja Gajaria, Tiffany Traina, Haruna A. Nggada, Abidemi Omonisi, Saad A. Ahmed, Emad A. Rakha, Padmashree Rida, Ritu Aneja
Publikováno v:
Cancers, Vol 11, Iss 7, p 995 (2019)
Background: The androgen receptor (AR) has emerged as a potential therapeutic target for AR-positive triple-negative breast cancer (TNBC). However, conflicting reports regarding AR’s prognostic role in TNBC are putting its usefulness in question. S
Externí odkaz:
https://doaj.org/article/69e6cfc3e13f41a897e315cbf8e195ee
Autor:
Emer Caffrey, Helen Ingoldsby, Deirdre Wall, Mark Webber, Kate Dinneen, Laura S Murillo, Celine Inderhaug, John Newell, Sanjeev Gupta, Grace Callagy
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e83724 (2013)
BACKGROUND: Dicer, an RNase III-type endonuclease, is the key enzyme involved in RNA interference and microRNA pathways. Aberrant expression of Dicer is reported in several human cancers. Our aim was to assess the prognostic role of Dicer in breast c
Externí odkaz:
https://doaj.org/article/cb3e6fa8fcfb4ee4810770e1de668d1f
Publikováno v:
Cancer Research. 83:P4-08
Human endogenous retrovirus K (HERV-K) belongs to a family of endogenous retroviruses that are present in our genome with similarities to present day exogenous retroviruses. This virus can express several proteins but our knowledge of HERV-K expressi
Autor:
Ayaka Katayama, Jane Starczynski, Michael S Toss, Abeer M Shaaban, Elena Provenzano, Cecily M Quinn, Grace Callagy, Colin A Purdie, Rebecca Millican‐Slater, David Purnell, Leena Chagla, Tetsunari Oyama, Sarah E Pinder, Steve Chan, Ian Ellis, Andrew H S Lee, Emad A Rakha
Publikováno v:
Histopathology. 81:511-519
Chromosome 17 alterations affect the assessment of HER2 gene amplification in breast cancer (BC), but its clinical significance remains unclear. This study aimed to identify the prevalence of centromere enumeration probe 17 (CEP17) alterations, and i